Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 461 to 470 of 1525

TitleReference numberPublishedLast updated
Nivolumab with ipilimumab for untreated unresectable malignant pleural mesotheliomaTA818
Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapiesTA819
Type 1 diabetes in adults: diagnosis and managementNG17
SecurAcath for securing percutaneous cathetersHTG440
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDsTA815
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancerTA816
Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrenceTA817
Stockholm3 for prostate cancer screeningMIB303
Aortic remodelling hybrid stent insertion during surgical repair of an acute type A aortic dissectionHTG634
Bioresorbable stent implantation to treat coronary artery diseaseHTG633

Results per page

  1. 10
  2. 25
  3. 50
  4. All